Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA: 603882)

Guangzhou Kingmed Diagnostics Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,944	2,458	2,929	2,653	1,635	954.94
Cash & Short-Term Investments	1,944	2,458	2,929	2,653	1,635	954.94
Cash Growth	-5.56%	-16.08%	10.37%	62.26%	71.25%	13.42%
Accounts Receivable	5,181	5,399	7,136	4,804	2,771	1,570
Other Receivables	91.23	76.98	91.65	66.1	54.86	46.79
Receivables	5,272	5,476	7,227	4,870	2,826	1,616
Inventory	219.73	248.21	405.25	345.14	238.13	171.51
Prepaid Expenses	-	47.43	48.94	43	43.01	34.72
Other Current Assets	166.88	35.5	49.49	18.74	19.09	17.68
Total Current Assets	7,603	8,265	10,660	7,930	4,762	2,795
Property, Plant & Equipment	2,150	2,305	2,215	1,968	1,225	1,091
Long-Term Investments	550.05	554.25	353.63	358.32	235.19	179.5
Goodwill	52.21	52.21	32.68	13.35	13.35	13.35
Other Intangible Assets	157.71	150.33	152	68.41	138.63	79.85
Long-Term Deferred Tax Assets	236.49	151.11	86.34	36.11	15.47	12.26
Long-Term Deferred Charges	189.78	245.24	255.19	197.69	176.87	150.57
Other Long-Term Assets	39.93	44.15	137.95	179.11	73.23	73.28
Total Assets	10,978	11,768	13,893	10,751	6,639	4,395
Accounts Payable	1,783	2,065	2,988	2,283	1,627	1,088
Accrued Expenses	159.22	355.61	995.92	834.42	251.61	188.04
Short-Term Debt	1	1	-	-	37.17	-
Current Portion of Long-Term Debt	139.6	14.83	137.66	130.93	-	255.97
Current Portion of Leases	-	115.51	84	70.04	-	-
Current Income Taxes Payable	86.26	15.49	231.97	228.13	101.13	15.61
Current Unearned Revenue	57.23	76.78	104.62	131.8	93.06	-
Other Current Liabilities	94.63	44.82	38	50.03	201.93	100.79
Total Current Liabilities	2,321	2,689	4,580	3,728	2,311	1,649
Long-Term Debt	438.82	267.61	143	248.74	379.19	358.7
Long-Term Leases	133.48	180.26	203.63	172.39	-	-
Long-Term Unearned Revenue	20.81	24.97	24.42	37.45	52.88	54.68
Long-Term Deferred Tax Liabilities	51.21	58.26	64.4	41.63	19.22	7.6
Total Liabilities	2,965	3,220	5,016	4,228	2,763	2,070
Common Stock	468.77	468.77	467.14	465.59	459.49	457.88
Additional Paid-In Capital	1,510	1,515	1,517	1,377	923.89	856.93
Retained Earnings	6,129	6,443	6,632	4,473	2,406	958.17
Treasury Stock	-300	-89.99	-	-	-	-
Comprehensive Income & Other	22.99	26.03	18.04	-11.76	-1.76	1.8
Total Common Equity	7,832	8,363	8,633	6,304	3,787	2,275
Minority Interest	181.48	184.56	243.4	218.78	89.37	50.93
Shareholders' Equity	8,013	8,547	8,877	6,523	3,877	2,326
Total Liabilities & Equity	10,978	11,768	13,893	10,751	6,639	4,395
Total Debt	712.9	579.21	568.3	622.1	416.36	614.67
Net Cash (Debt)	1,231	1,878	2,360	2,031	1,219	340.27
Net Cash Growth	-17.37%	-20.42%	16.20%	66.65%	258.22%	253.86%
Net Cash Per Share	2.64	4.03	5.06	4.36	2.64	0.74
Filing Date Shares Outstanding	463.9	464.79	467.3	465.59	459.49	457.88
Total Common Shares Outstanding	463.9	468.12	467.14	465.59	459.49	457.88
Working Capital	5,282	5,576	6,079	4,202	2,450	1,146
Book Value Per Share	16.88	17.86	18.48	13.54	8.24	4.97
Tangible Book Value	7,622	8,160	8,449	6,222	3,635	2,182
Tangible Book Value Per Share	16.43	17.43	18.09	13.36	7.91	4.76
Buildings	-	658.02	577.61	570.99	570.99	570.39
Machinery	-	2,945	2,748	2,237	1,582	1,230
Construction In Progress	-	359.11	205.53	143.15	17.73	10.6

Source: S&P Capital IQ. Standard template. Financial Sources.